{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-127167","form_type":"8-K","ticker":"ELUT","cik":"0001708527","company_name":"ELUTIA INC.","filed_at":"2022-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.787315+00:00","generated_at":"2026-06-21T04:12:56.933476+00:00","sec_items":["2.03","1.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Aziyo Biologics draws additional $4M term loan, total borrowings reach $25M","bullets":["Drew $4.0 million Subsequent Term Loan under existing Credit Agreement on December 13, 2022.","Total borrowings now $25 million, comprising $21M initial term loan, $4M draw, and ~$0.3M paid-in-kind interest.","Credit Agreement dated August 10, 2022 with SWK Funding LLC as administrative agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-127167","json":"https://secwatch.observer/filing/0001104659-22-127167.json","markdown":"https://secwatch.observer/filing/0001104659-22-127167.md","text":"https://secwatch.observer/filing/0001104659-22-127167.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708527/000110465922127167/0001104659-22-127167-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708527/000110465922127167/tm2232775d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T04:12:56.933476+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4c5d0ff2c5fc7089bfc7235f4fe7ab3b7004133a","claim":"ELUTIA INC. incurred term loan of $4.0 million with SWK Funding LLC.","evidence_excerpt":"On December 13, 2022, Aziyo Biologics, Inc. (the “Company”) elected to draw the additional term loan of $4.0 million (the “Subsequent Term Loan”) under its previously disclosed Credit Agreement, dated as of August 10, 2022 (as amended, restated, supplemented, or otherwise modified prior to the date hereof, the “Credit Agreement”), by and among the Company, as the Borrower, and its subsidiaries, as the other loan parties, the financial institutions party thereto from time to time as lenders, and SWK Funding LLC, as administrative agent and collateral agent for all lenders.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708527/000110465922127167/0001104659-22-127167-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"$4.0 million"},{"label":"Counterparty","value":"SWK Funding LLC"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}